-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 JrfZjm/0lqQT0vYIkvYhhRoL6fU1ZwPnpoTCnv3PMEfGP6mAeuN1O8RJRrxSlC5m
 /yWhJssvrlk9mr5gkQBzZw==

<SEC-DOCUMENT>0000950123-05-001854.txt : 20050215
<SEC-HEADER>0000950123-05-001854.hdr.sgml : 20050215
<ACCEPTANCE-DATETIME>20050215094522
ACCESSION NUMBER:		0000950123-05-001854
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20041231
FILED AS OF DATE:		20050215
DATE AS OF CHANGE:		20050215
EFFECTIVENESS DATE:		20050215

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PHIBRO ANIMAL HEALTH CORP
		CENTRAL INDEX KEY:			0001069899
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				131840497
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	333-64641
		FILM NUMBER:		05614966

	BUSINESS ADDRESS:	
		STREET 1:		ONE PARKER PLZ
		CITY:			FORT LEE
		STATE:			NJ
		ZIP:			07024
		BUSINESS PHONE:		2019446020

	MAIL ADDRESS:	
		STREET 1:		ONE PARKET PLZ
		CITY:			FORT LEE
		STATE:			NJ
		ZIP:			07024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHILIPP BROTHERS CHEMICALS INC
		DATE OF NAME CHANGE:	19980908
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>y05870ntnt10vq.txt
<DESCRIPTION>NT 1O-Q
<TEXT>
<PAGE>
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                   FORM 12B-25


                           NOTIFICATION OF LATE FILING

                                                 SEC FILE NUMBER 333-64641
                                                 CUSIP NUMBER 71820 AC 3

(Check One): /_/ Form 10-K  /_/ Form 20-F  /_/ Form 11-K  /X/ Form 10-Q
             /_/ Form N-SAR


                      For Period Ended: December 31, 2004

                      /_/  Transition Report on Form 10-K

                      /_/  Transition Report on Form 20-F

                      /_/  Transition Report on Form 11-K

                      /_/  Transition Report on Form 10-Q

                      /_/  Transition Report on Form N-SAR

                      For the Transition Period Ended: ____________


    NOTHING IN THIS FORM SHALL BE CONSTRUED TO IMPLY THAT THE COMMISSION HAS
                   VERIFIED ANY INFORMATION CONTAINED HEREIN.

If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: _____________________


PART I - REGISTRANT INFORMATION

Phibro Animal Health Corporation
- --------------------------------------------------------------------------------
Full Name of Registrant

N/A
- --------------------------------------------------------------------------------
Former Name if Applicable

65 Challenger Road
- --------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)

Ridgefield Park, New Jersey 07660
- --------------------------------------------------------------------------------
City, State and Zip Code


PART II - RULES 12B-25(B) AND (C)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)     /X/

       (a) The reasons described in reasonable detail in Part III of this form
           could not be eliminated without unreasonable effort or expense;

       (b) The subject annual report, semi-annual report, transition report on
           Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof, will be
           filed on or before the fifteenth calendar day following the
           prescribed due date; or the subject quarterly report or transition
           report on Form 10-Q, or portion thereof will be filed on or before
           the fifth calendar day following the prescribed due date; and

       (c) The accountant's statement or other exhibit required by Rule
           12b-25(c) has been attached if applicable.
<PAGE>
PART III - NARRATIVE

State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribed time period. The Registrant requires additional time to determine
the accounting treatment for the sale of its Rixensart, Belgium plant and
related assets under a Purchase Agreement dated December 16, 2004.


PART IV - OTHER INFORMATION

(1)      Name and telephone number of person to contact in regard to this
         notification


         Richard G. Johnson            (201)                    329-7300
         ------------------     ------------------        ------------------
                (Name)              (Area Code)           (Telephone Number)

(2)      Have all other periodic reports required under Section 13 or 15(d) of
         the Securities Exchange Act of 1934 or Section 30 of the Investment
         Company Act of 1940 during the preceding 12 months or for such shorter
         period that the registrant was required to file such report(s) been
         filed? If answer is no, identify report(s).          /X/ Yes /_/ No

- --------------------------------------------------------------------------------

(3)      Is it anticipated that any significant change in results of operations
         from the corresponding period for the last fiscal year will be
         reflected by the earnings statements to be included in the subject
         report or portion thereof?                           /_/ Yes /X/ No

         If so, attach an explanation of the anticipated change, both
         narratively and quantitatively, and, if appropriate, state the reasons
         why a reasonable estimate of the results cannot be made.

- --------------------------------------------------------------------------------

                        Phibro Animal Health Corporation.
                  --------------------------------------------
                  (Name of Registrant as Specified in Charter)


has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date: February 14, 2005         By: /s/ Richard G. Johnson
                                    ---------------------------
                                         Richard G. Johnson
                                      Chief Financial Officer
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
